PubMed Health⌕ Search

PubMed · 12696766

Current trends and technique in OPCAB surgery.

Abstract

BACKGROUND AND AIM OF THE STUDY: Aging of the population, increased surgical risk, and technical improvement have contributed to the recent revival of off pump coronary artery bypass surgery (OPCAB). We present our experience with the systematic use of this technique. METHODS: Between September 1996 and June 2000, 500 OPCAB procedures were performed at the Montreal Heart Institute (95% of all procedures during time frame, single surgeon). Contraindications were unstable hemodynamics, intramyocardial left anterior descending artery, and reoperation with extensive adhesions. Stabilization was achieved with pericardial sutures and mechanical compression. Surgical strategy was to first bypass the culprit lesion. Anesthetic management consisted of adequate fluid loading and minimal use of alpha-agonist. This cohort was compared to a contemporary cohort of 1,444 patients operated with cardiopulmonary bypass (CPB). RESULTS: Demographics and risk factors were comparable for all. OPCAB patients received more grafts (3.1 +/- 0.9 vs 2.9 +/- 0.7, p = 0.006), conversion rate was low (0.4%), and complete revascularization was achieved in 93%. Operative mortality and perioperative myocardial infarction were comparable in both groups. Transfusion need, CK-MB count, postoperative use of intra-aortic balloon pump, and creatinine increase were less significant in OPCAB. Postoperative hemorrhage, atrial fibrillation, prevalence of cerebrovascular accident, and hospital stay were comparable for both groups. These results are comparable to those currently reported in the literature. CONCLUSION: OPCAB surgery in the current era has established its safety and short-term efficacy although long-term clinical results are still warranted. Considering the changing pattern in surgical practice, OPCAB surgery should remain a therapeutic option in modern cardiac surgery.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Raymond Cartier. Current trends and technique in OPCAB surgery.. https://doi.org/10.1046/j.1540-8191.2003.01907.x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

A MAGIBU-based model for pediatric and juvenile CNS tumors: an in-house epigenetic decision-support framework compared with online DNA methylation classifiers.

Background: DNA methylation profiling is a tool that provides key support for central nervous system (CNS) tumor classification. However, diagnostically ambiguous pediatric cases may result in discordant outputs across classifiers. We developed MAGIBU, a cross-platform, projection-based framework that embeds individual methylomes into a fixed CNS reference landscape, ranking diagnostic entities by local epigenetic proximity to support clinician-led integrative diagnosis. Methods: As a proof-of-concept, we evaluated MAGIBU in eight morphologically challenging pediatric/juvenile CNS tumors with unresolved diagnoses after institutional and central pathology review. To establish a benchmark in the absence of a definitive histopathological ground truth, a consensus epigenetic reference was defined a priori for cases showing concordant results between the Heidelberg CNS Tumor Methylation Classifier and Methylscape Analysis. Comparisons were also performed with Epigenomic Digital Pathology (EpiDiP). To validate MAGIBU beyond this discovery cohort, performance was assessed at the family level across the CNS methylation spectrum (n = 678, 28 methylation families), on non-array platforms (whole-genome bisulfite sequencing and Oxford Nanopore), and in a focused analysis of the low-grade glioma and diffuse midline glioma compartment across four independent cohorts (n = 670). Results: In the discovery cohort, MAGIBU achieved high concordance with the consensus reference (Cohen's κ = 0.855), outperforming EpiDiP (κ = 0.278), which frequently placed low-grade tumors in proximity to higher-grade reference regions. Conclusions: MAGIBU provides a stable, quantitative differential diagnosis framework that mitigates the limitations of rigid categorical assignments. By leveraging a distance-based proximity metric, it offers a transparent decision-support tool that integrates effectively with clinical, radiological, and molecular data. While performance is inherently dependent on reference atlas composition, MAGIBU represents a robust complementary approach for the diagnostic workup of ambiguous CNS tumors.

Brain↗

1q21.1 distal copy number variants are associated with cerebral and cognitive alterations in humans.

Low-frequency 1q21.1 distal deletion and duplication copy number variant (CNV) carriers are predisposed to multiple neurodevelopmental disorders, including schizophrenia, autism and intellectual disability. Human carriers display a high prevalence of micro- and macrocephaly in deletion and duplication carriers, respectively. The underlying brain structural diversity remains largely unknown. We systematically called CNVs in 38 cohorts from the large-scale ENIGMA-CNV collaboration and the UK Biobank and identified 28 1q21.1 distal deletion and 22 duplication carriers and 37,088 non-carriers (48% male) derived from 15 distinct magnetic resonance imaging scanner sites. With standardized methods, we compared subcortical and cortical brain measures (all) and cognitive performance (UK Biobank only) between carrier groups also testing for mediation of brain structure on cognition. We identified positive dosage effects of copy number on intracranial volume (ICV) and total cortical surface area, with the largest effects in frontal and cingulate cortices, and negative dosage effects on caudate and hippocampal volumes. The carriers displayed distinct cognitive deficit profiles in cognitive tasks from the UK Biobank with intermediate decreases in duplication carriers and somewhat larger in deletion carriers-the latter potentially mediated by ICV or cortical surface area. These results shed light on pathobiological mechanisms of neurodevelopmental disorders, by demonstrating gene dose effect on specific brain structures and effect on cognitive function.

Brain↗